Video

Dr. Baker on Integrating Palliative Care into Pediatric Oncology

Justin N. Baker, MD, chief, Division of Quality of Life and Palliative Care, attending physician, Quality of Life Service, St. Jude Children’s Research Hospital, discusses integrating palliative care into the treatment of pediatric oncology.

Justin N. Baker, MD, chief, Division of Quality of Life and Palliative Care, attending physician, Quality of Life Service, St. Jude Children’s Research Hospital, discusses integrating palliative care into the treatment of pediatric oncology.

Palliative care is coming of age in pediatric oncology, says Baker. If palliative care is integrated early, it is much easier for patients and families to emphasize quality of life and recognize good days during treatment. Baker says that it is better and easier than what is traditionally done, which is a hard stop when curative treatment fails, and then a complete switch to palliative care. It is not good for the oncology team, the palliative care team, and most of all, it is not good for the patient or their family, he explains.

Integration is happening earlier at most institutions, which is great for patients, families, palliative care teams, and for the pediatric oncology team, as well. Taking on all the factors of palliative care at once is too much, Baker says, and specialty teams need to work together hand in hand. These partnerships make a difference in patient’s lives, as well as their families’ lives, Baker concludes.

Related Videos
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD
Vikram M. Narayan, MD
C. Ola Landgren, MD, PhD
Timothy Yap, MBBS, PhD, FRCP